'It's Time': AdvaMed Device Tax Ad Campaign Sets Sights On Key Lawmakers
While lawmakers are back in their districts during Congress' recess, AdvaMed is running local ads aimed at major congressional leaders to ensure they continue to prioritize repealing the 2.3% medical device excise tax.
You may also be interested in...
US Congress successfully pushed through a user-fee bill in 2017 to help smooth the regulatory path at FDA for medical devices and other products, but other efforts, including several industry priorities, remain undone. On top on the list, of course, is the effort to repeal the device excise tax. But legislation is also on the table to address diagnostics regulation, telehealth reimbursement, and medtech cybersecurity vulnerability, among other issues. Here is a look at the medtech landscape in Congress in 2018.
The large medical device lobby group is keeping up its efforts to repeal the medical device excise tax, expanding its advertising buy on Capitol Hill with a new campaign as lawmaker return from recess.
A group of high-level health policy analysts – including former Medicare and Medicaid officials and experts at policy groups including Families USA and the American Enterprise Institute – have crafted a bipartisan recommendation for Affordable Care Act reform, but are divided on if the 2.3% device excise tax created by ACA should be repealed.